Stagwell's Allison Worldwide Launches Health Group as Q2 Revenue Rises 11% to $786 Million

Insider Monkey··US·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Allison Worldwide, a health communications agency under Stagwell Inc., launched the Allison Worldwide Health Group on September 17, a unit targeting rare disease treatments, women's health and specialty medicine over the next five years and led by global CEO Wendy Lund. The launch follows Stagwell's second-quarter report on July 30, when total revenue rose 11% year over year to $786 million, net revenue climbed 6% to $632 million and organic net revenue advanced 5%. Digital transformation work grew net revenue 18% organically to $107 million, while adjusted EBITDA rose 15% to $109 million, holding a 17% margin on net revenue. The net loss attributable to Stagwell shareholders widened to $8 million from $5 million a year earlier, pushing the year-to-date loss to $21 million versus $8 million, for a GAAP loss per share of $0.03. Twelve hedge funds held the stock in the most recent quarter, down from 17, short interest sits at 10.26% of the float, and shares trade at 5.87 times forward earnings.

Impact on assets 2

Communication Services▲
Stagwell Inc
STGW
▲ PositiveCapitalDemandrelevance

Stagwell's Q2 revenue rose 11% to $786M with adjusted EBITDA up 15% and 17% margin, though net loss widened to $8M.

Artificial Intelligence▲

Off-coverage companies 1

Allison Worldwidei
Private▲ PositiveDemandrelevance

Allison Worldwide launched the Allison Worldwide Health Group targeting rare disease, women's health and specialty medicine over the next five years.